Medications for Blastic Plasmacytoid Dendritic Cell Neoplasm

1 result
  • elzonris - tagraxofusp injection, solution

    (Tagraxofusp)
    Stemline Therapeutics, Inc.
    Elzonris treats blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients aged 2 years and older.